IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q2 2024 Holdings

Filed 2024-08-08 | 15 holdings | $231.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$153.7M6,068,12566.5%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$21.0M1,025,0009.1%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$16.1M1,115,3527.0%
Elevation Oncology Inc (Elev)COM28623U101$7.7M2,834,9103.3%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$7.4M2,541,0093.2%
Compass Pathways Plc (Cmps)(CMPS)SPONSORED ADS20451W101$5.8M964,5002.5%
Monte Rosa Therapeutics Inc (Glue)(GLUE)COM61225M102$5.5M1,472,3312.4%
Biomea Fusion Inc (Bmea)(BMEA)COM09077A106$3.6M798,7571.6%
Poseida Therapeutics Inc. (Pstx)(PSTXUSD)COM73730P108$3.0M1,043,2671.3%
CalciMedica, Inc. (Calc)(CALC)COM NEW38942Q202$2.1M521,1140.9%
Marker Therapeutics, Inc. (Mrkr)(MRKR)COM NEW57055L206$1.7M314,2860.7%
Tectonic Therapeutic Inc (Tecx)(TECX)COM878972108$1.4M84,1480.6%
Reneo Pharmaceuticals Inc (Rphm)(RPHM)COM75974E103$1.3M886,0750.6%
Aclaris Therapeutics Inc (Acrs)(ACRS)COM00461U105$477.9K434,4550.2%
Viracta Therapeutics Inc (Virx)COM92765F108$156.9K288,5710.1%